Patents Assigned to Purdue Pharmaceuticals, L.P.
  • Pharmaceutical Formulation Containing Gelling Agent
    Publication number: 20170296533
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 19, 2017
    Applicants: The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • Tamper resistant dosage forms
    Patent number: 9775808
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9775809
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9775811
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9775810
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9775812
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Process for preparing oxycodone compositions
    Patent number: 9777011
    Abstract: In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: October 3, 2017
    Assignees: PURDUE PHARMA L.P., THE P.F. LABORATORIES, INC., PURDUE PHARMACEUTICALS L.P., RHODES TECHNOLOGIES
    Inventors: Robert Chapman, Lonn S. Rider, Qi Hong, Donald Kyle, Robert Kupper
  • Tamper resistant dosage forms
    Patent number: 9770416
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: September 26, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9770417
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: September 26, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Tamper resistant dosage forms
    Patent number: 9763886
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: September 19, 2017
    Assignees: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Pharmaceutical formulation containing gelling agent
    Patent number: 9757341
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: September 12, 2017
    Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170246116
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: May 17, 2017
    Publication date: August 31, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • Pharmaceutical formulation containing gelling agent
    Patent number: 9693961
    Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: July 4, 2017
    Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.
    Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128374
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128370
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128369
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128373
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128371
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128375
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
  • TAMPER RESISTANT DOSAGE FORMS
    Publication number: 20170128440
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.
    Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG